Indian equity markets showed resilience on Monday as benchmark indices traded higher in early sessions, shrugging off mixed cues from global markets.
The GIFT Nifty futures indicated a positive start for the Indian market, providing early optimism for traders ahead of the full open.
By late morning, the BSE Sensex was up over 100 points while the Nifty 50 climbed above 25,500, supported by buying interest in energy and banking stocks.
Heavyweights such as HDFC Bank and Reliance Industries contributed to the gains, helping the benchmarks hold their ground despite a lack of broad participation.
Market breadth, however, remained weak with more stocks declining than advancing on the exchanges, a sign of caution among investors.
While financial and defensive sectors witnessed buying, the IT pack remained under pressure with major tech names trading lower, keeping the recovery uneven.
Broader indices such as midcaps and smallcaps were largely flat, and the India VIX — a measure of market volatility — edged higher, signalling lingering uncertainty.
Natco Pharma stood out with strong gains after regulatory approval to launch a generic version of Semaglutide, boosting pharma sector sentiment.
Overall, domestic markets showed a positive bias in early trade, with investors balancing mixed global signals against robust buying in key sectors.
Indian stock markets ne Monday ko early trade mein achha performance dikhaya, jab benchmark indices higher trade kar rahe the, mixed global cues ke beech bhi.
GIFT Nifty futures ne positive start ka signal diya, jo traders ke liye ek optimism create kar raha tha market open se pehle.
Late morning tak, BSE Sensex 100+ points upar aur Nifty 50 25,500 ke upar trade kar raha tha, mainly energy aur banking stocks mein buying interest ke wajah se.
HDFC Bank aur Reliance Industries jaise heavyweights ne gains ko support kiya, lekin overall participation abhi bhi limited thi.
Market breadth thodi weak rahi, jahan zyada stocks decline kar rahe the as compared to advance, jo investor caution ko dikhata hai.
Financial aur defensive sectors mein buying thi, lekin IT stocks pressure mein the, jisse recovery uneven rahi.
Broader indices jaise midcaps aur smallcaps largely flat the, aur India VIX slightly upar gaya, jo market mein thodi uncertainty dikha raha hai.
Natco Pharma standout raha, generic Semaglutide launch approval ke baad strong gains ke saath, jo pharma sector ko boost de raha hai.
Overall, domestic markets early trade mein positive bias dikhate hue, mixed global signals ke bawajood, key sectors mein strong buying ke saath trade kar rahe hain.